Survival and quality-of-life outcomes in early-stage NSCLC patients: a literature review of real-world evidence.
Nick JovanoskiKathleen BowesAudrey BrownRossella BelleliDanilo Di MaioShkun ChaddaSeye AbogunrinPublished in: Lung cancer management (2023)
Despite curative-intent therapy, survivors of eNSCLC still face significant risks of recurrence, excess mortality, and diminished quality-of-life.
Keyphrases
- early stage
- prognostic factors
- end stage renal disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- free survival
- young adults
- stem cells
- cardiovascular events
- human health
- rectal cancer
- cardiovascular disease
- type diabetes
- squamous cell carcinoma
- mesenchymal stem cells
- risk assessment
- coronary artery disease
- skeletal muscle
- climate change
- patient reported outcomes
- bone marrow
- lymph node
- locally advanced
- cell therapy